Vero Biotech Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2017-09-29. The offering totals $35.1M, of which $29.9M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 31 people.
| Name | Role | Location |
|---|---|---|
| Todd Scott Brady | Director | Cocoa, FL |
| David H Fine, Ph.D. | Director | Cocoa, FL |
| Brent H Furse | Director | Cocoa, FL |
| T. Scott Johnson, M.D. | Director | Cocoa, FL |
| Theo Scott Melas-Kyriazi | Director | Cocoa, FL |
| Vinzenz Scott Ploerer | Director | Cocoa, FL |
| Dan Scott Salazar, Ph.D. | Director | Cocoa, FL |
| Paul Scott Antinori | Executive Officer | Concord, MA |
| David H Fine, Ph.D. | Executive Officer | Cocoa, FL |
| Brent H Furse | Executive Officer | Cocoa, FL |
| Anthony Scott Loumidis | Executive Officer | Cocoa, FL |
| Tod Scott Shultz | Executive Officer | Cocoa, FL |
| James O'Brien | Director | New York, NY |
| James O'Brien | Executive Officer | New York, NY |
| Daniel Salazar | Director | Clinton, MA |
| Todd Brady | Director | Atlanta, GA |
| Thiago V Tavares | Director | Atlanta, GA |
| Shasha V Zou | Executive Officer | Atlanta, GA |
| Eric V Bednarski | Director | Atlanta, GA |
| Brent V Furse | Director | Atlanta, GA |
| Brent V Furse | Executive Officer | Atlanta, GA |
| Roberto V Cohen | Executive Officer | Atlanta, GA |
| Steven Shulman | Director | New York, NY |
| Steven Shulman | Executive Officer | New York, NY |
| Theo Melas-Kyriazi | Director | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2021-12-22 | D | $99.5M | $27.3M |
| 2013-10-18 | D/A | $17.0M | $14.7M |
| 2013-10-03 | D | $14.6M | $14.6M |
| 2011-12-29 | D | $10.5M | $8.0M |
| 2009-09-14 | D | $3.0M | $2.1M |
| 2009-09-14 | D | $3.5M | $2.1M |